Publications (original articles or review articles) published in 2022 from OUS - Department of Urology
8 publications found
Management of Recurrent Cystitis in Women: When Prompt Identification of Risk Factors Might Make a Difference
Eur Urol Focus (in press)
DOI 10.1016/j.euf.2022.01.014, PubMed 35135727
Renal Cell Carcinoma and Kidney Transplantation: A Narrative Review
Transplantation, 106 (1), e52-e63
DOI 10.1097/TP.0000000000003762, PubMed 33741842
A Multivariable Approach Using Magnetic Resonance Imaging to Avoid a Protocol-based Prostate Biopsy in Men on Active Surveillance for Prostate Cancer-Data from the International Multicenter Prospective PRIAS Study
Eur Urol Oncol (in press)
DOI 10.1016/j.euo.2022.03.007, PubMed 35437217
Primary versus secondary muscle-invasive bladder cancer: survival after curative treatment
Scand J Urol, 1-7 (in press)
DOI 10.1080/21681805.2022.2056633, PubMed 35506475
To Transect or Not Transect: Results from the Scandinavian Urethroplasty Study, A Multicentre Randomised Study of Bulbar Urethroplasty Comparing Excision and Primary Anastomosis Versus Buccal Mucosal Grafting
Eur Urol, 81 (4), 375-382
DOI 10.1016/j.eururo.2021.12.017, PubMed 35012771
The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource
Cancer Epidemiol Biomarkers Prev, 31 (4), 715-727
DOI 10.1158/1055-9965.EPI-21-0600, PubMed 35131885
Association of β-Blocker Use at Time of Radical Prostatectomy With Rate of Treatment for Prostate Cancer Recurrence
JAMA Netw Open, 5 (1), e2145230
DOI 10.1001/jamanetworkopen.2021.45230, PubMed 35080602
SUsceptibility and Resistance to Fosfomycin and other antimicrobial agents among pathogens causing lower urinary tract infections: findings of the SURF study
Int J Antimicrob Agents, 59 (5), 106574
DOI 10.1016/j.ijantimicag.2022.106574, PubMed 35307561